Wearable Injectors Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Chronic Medical Conditions
- Technological Developments in Drug Delivery Injectors Globally
Challenges
- Emergence of Alternative Drug Delivery Systems
- Lack of Reimbursement Policies in Low and Middle-Income Regions
Wearable Injectors Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
10.6% |
|
Base Year Market Size (2024) |
USD 9.54 billion |
|
Forecast Year Market Size (2037) |
USD 35.35 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of wearable injectors is estimated at USD 10.4 billion.
Wearable Injectors Market size was valued at USD 9.54 billion in 2024 and is likely to cross USD 35.35 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is set to hold largest revenue share by 2037, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region.
The major players in the market include Amgen Inc., Insulet Corporation, YPSOMED AG, among others.
